Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Andrx Altocor Sales Force Expands 50%; Generic Prilosec Charge Is $41 Mil.

Executive Summary

Andrx plans to increase its sales force to 450 reps to support the cholesterol agent Altocor, CEO Richard Lane said during an Oct. 31 conference call

You may also be interested in...



Schwarz Generic Prilosec Clears FDA After Deal With Andrx, Genpharm

Schwarz is expected to launch generic omeprazole by the end of year after FDA approval Nov. 1

Schwarz Generic Prilosec Clears FDA After Deal With Andrx, Genpharm

Schwarz is expected to launch generic omeprazole by the end of year after FDA approval Nov. 1

Generic Prilosec Launch Awaits Negotiations Between Andrx And Schwarz

Andrx is considering licensing its 180-day exclusivity for generic omeprazole to Schwarz Pharma following an Oct. 11 federal court ruling that Andrx' product infringes AstraZeneca's Prilosec patents, but Schwarz' does not

Related Content

UsernamePublicRestriction

Register

PS040708

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel